Neuronavigated dual-target transcranial magnetic stimulation for schizophrenia negative symptoms.
Findings suggest neuronavigated dual-target rTMS over rDLPFC and cerebellum may be associated with numerical improvements in negative symptoms in early-stage psychosis.